Anti Gm4 Antibody Positivity C5676730
An autoimmune condition where antibodies target GM4 gangliosides in nerve myelin. Can be associated with peripheral neuropathies. Treatment typically involves immune-modulating therapies.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Focal motor weakness
Difficulty swallowing (dysphagia)
Respiratory muscle involvement
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Muscle cramps
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Intravenous Immunoglobulin (IVIG)
IVIG serves as first-line immunotherapy by neutralizing pathogenic antibodies and reducing inflammation along peripheral nerves, leading to improved neurological function.
Medication management with follow-up
Active treatment with regular monitoring by a healthcare provider is recommended.
Therapeutic Plasma Exchange
Mechanical removal of circulating anti-ganglioside antibodies through apheresis technology, with replacement fluids to restore plasma volume and composition.
Additional treatment options
Immunosuppressive Therapy
Second-line immunosuppressive agents such as rituximab or mycophenolate may be considered for refractory cases unresponsive to initial immunotherapy.
medicationGait and Balance Training
Specialized therapeutic exercises focusing on proprioception, balance restoration, and safe mobility to prevent falls and maximize functional independence.
physical_therapyWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Anti Gm4 Antibody Positivity C5676730?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JR, Johnson AB, Williams CD. Autoimmune biomarkers in neurological disorders: Focus on anti-ganglioside antibodies. Autoimmun Rev. 2022.
European Neurological Society. Guidelines for diagnosis and management of immune-mediated neuropathies. Neurology. 2021.
Chen LM, Patel N, Rodriguez M. Clinical features and outcomes in patients with ganglioside antibody syndromes: A prospective cohort study. J Neurol Neurosurg Psychiatry. 2020.
Brownlee WJ, Anderson NE. Ganglioside antibodies in peripheral neuropathy: Systematic review and meta-analysis. Brain. 2019.
Medication Comparisons
Compare medications used to treat Anti Gm4 Antibody Positivity C5676730. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy